Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Peerawong Werarak
39  Ergebnisse:
Personensuche X
?
1

A pilot program of HIV pre-exposure prophylaxis in Thai you..:

Rungmaitree, Supattra ; Werarak, Peerawong ; Pumpradit, Wadchara...
PLOS ONE.  19 (2024)  2 - p. e0298914 , 2024
Link: https://doi.org/10.1371/..
 
?
2

1614. Efficacy and Safety of Adjusted Renal Dosing of Tenof..:

Yamasmith, Eakkawit ; Sirijatuphat, Rujipas ; Ratanasuwan, Winai.
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
3

A Risk Prediction Model and Risk Score of SARS-CoV-2 Infect..:

Sripanidkulchai, Kantarida ; Rattanaumpawan, Pinyo ; Ratanasuwan, Winai...
Tropical Medicine and Infectious Disease.  7 (2022)  9 - p. 248 , 2022
Link: https://doi.org/10.3390/..
 
?
4

Occupational Post-exposure Prophylaxis after Blood and Body..:

Changraksa, Narasak ; Pannapoch, Ladda ; Phatharodom, Phatharajit...
Siriraj Medical Journal.  74 (2022)  11 - p. 787-791 , 2022
Link: https://doi.org/10.33192..
 
?
5

Depression and Anxiety in Youth and Young Adults Living wit..:

Chantaratin, Sasitorn ; Trimetha, Kawita ; Werarak, Peerawong...
Journal of the International Association of Providers of AIDS Care (JIAPAC).  21 (2022)  - p. 232595822211018 , 2022
Link: https://doi.org/10.1177/..
 
?
6

Attitudes towards, knowledge about, and confidence to presc..:

Wisutep, Pruettichai ; Sirijatuphat, Rujipas ; Navanukroh, Oranich...
Medicine.  100 (2021)  49 - p. e28120 , 2021
Link: https://doi.org/10.1097/..
 
?
7

Efficacy and safety of de-escalation therapy to ertapenem f..:

Rattanaumpawan, Pinyo ; Werarak, Peerawong ; Jitmuang, Anupop..
BMC Infectious Diseases.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
8

Serological Response of Patients with Influenza A (H1N1) pd..:

Angkasekwinai, Nasikarn ; Kaewnapha, Bualan ; Waywa, Duangdao...
PLoS ONE.  8 (2013)  11 - p. e81436 , 2013
Link: https://doi.org/10.1371/..
 
?
9

Self-reported adverse events in adolescents while taking te..:

Supattra Rungmaitree ; Peerawong Werarak ; Wadchara Pumpradit...
doi:10.1371/journal.pone.0298914.s006.  , 2024
Link: https://doi.org/10.1371/..
 
?
10

Factors associated with adherence to pre-exposure prophylax..:

Supattra Rungmaitree ; Peerawong Werarak ; Wadchara Pumpradit...
doi:10.1371/journal.pone.0298914.t003.  , 2024
Link: https://doi.org/10.1371/..
 
?
11

Adherence to pre-exposure prophylaxis treatment in particip..:

Supattra Rungmaitree ; Peerawong Werarak ; Wadchara Pumpradit...
doi:10.1371/journal.pone.0298914.g002.  , 2024
Link: https://doi.org/10.1371/..
 
?
12

Factors associated with adherence to pre-exposure prophylax..:

Supattra Rungmaitree ; Peerawong Werarak ; Wadchara Pumpradit...
doi:10.1371/journal.pone.0298914.s003.  , 2024
Link: https://doi.org/10.1371/..
 
?
13

Factors associated with retention in the PrEP program:

Supattra Rungmaitree ; Peerawong Werarak ; Wadchara Pumpradit...
doi:10.1371/journal.pone.0298914.s001.  , 2024
Link: https://doi.org/10.1371/..
 
?
14

TFV-DP concentrations among participants by gender and adhe..:

Supattra Rungmaitree ; Peerawong Werarak ; Wadchara Pumpradit...
doi:10.1371/journal.pone.0298914.s002.  , 2024
Link: https://doi.org/10.1371/..
 
?
15

Self-reported adverse events in adolescents while taking te..:

Supattra Rungmaitree ; Peerawong Werarak ; Wadchara Pumpradit...
doi:10.1371/journal.pone.0298914.s006.  , 2024
Link: https://doi.org/10.1371/..
 
1-15